Literature DB >> 16806196

Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.

Muhammad Omar Chohan1, Sabiha Khatoon, Inge-Grundke Iqbal, Khalid Iqbal.   

Abstract

The activity of protein phosphatase (PP)-2A, which regulates tau phosphorylation, is compromised in Alzheimer disease brain. Here we show that the transient transfection of PC12 cells with inhibitor-2 (I2PP2A) of PP2A causes abnormal hyperphosphorylation of tau at Ser396/Ser404 and Ser262/Ser356. This hyperphosphorylation of tau is observed only when a sub-cellular shift of I2PP2A takes place from the nucleus to the cytoplasm and is accompanied by cleavage of I2PP2A into a 20 kDa fragment. Memantine, an un-competitive inhibitor of N-methyl-D-aspartate receptors, inhibits this abnormal phosphorylation of tau and cell death and prevents the I2PP2A-induced inhibition of PP2A activity in vitro. These findings demonstrate novel mechanisms by which I2PP2A regulates the intracellular activity of PP2A and phosphorylation of tau, and by which Memantine modulates PP2A signaling and inhibits neurofibrillary degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806196     DOI: 10.1016/j.febslet.2006.06.021

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  46 in total

Review 1.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Screening of treatment targets for Alzheimer's disease from the molecular mechanisms of impairment by β-amyloid aggregation and tau hyperphosphorylation.

Authors:  Lian-Feng Lin; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

3.  Accumulation of the SET protein in HEK293T cells and mild oxidative stress: cell survival or death signaling.

Authors:  Andréia M Leopoldino; Cristiane H Squarize; Cristiana B Garcia; Luciana O Almeida; Cezar R Pestana; Ana C M Polizello; Sérgio A Uyemura; Eloiza H Tajara; J Silvio Gutkind; Carlos Curti
Journal:  Mol Cell Biochem       Date:  2011-12-06       Impact factor: 3.396

4.  The N-terminal Set-β Protein Isoform Induces Neuronal Death.

Authors:  Ephraim F Trakhtenberg; Melina I Morkin; Karan H Patel; Stephanie G Fernandez; Alan Sang; Peter Shaw; Xiongfei Liu; Yan Wang; Gregory M Mlacker; Han Gao; Dmitry Velmeshev; Susan M Dombrowski; Michael P Vitek; Jeffrey L Goldberg
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

5.  Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.

Authors:  Lisette Arnaud; She Chen; Fei Liu; Bin Li; Sabiha Khatoon; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  FEBS Lett       Date:  2011-07-28       Impact factor: 4.124

Review 6.  Stratification of patients is the way to go to develop neuroprotective/disease-modifying drugs for Alzheimer's disease.

Authors:  Khalid Iqbal; M Omar Chohan; Inge Grundke-Iqbal
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

Review 7.  Novel therapeutic strategies for neurodegenerative disease.

Authors:  Hitoshi Tanimukai; Takashi Kudo; Toshihisa Tanaka; Inge Grundke-Iqbal; Khalid Iqbal; Masatoshi Takeda
Journal:  Psychogeriatrics       Date:  2009-06       Impact factor: 2.440

Review 8.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

9.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.